إعلان
إعلان
ANRO
Alto Neuroscience Inc.
15.97
USDبرعاية
+0.89
+5.92%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
15.95
-0.02
-0.14%
تقارير أرباح ANRO
النسبة الإيجابية المفاجئة
ANRO تفوق 5 من 8 آخر التقديرات.
63%
التقرير التالي
بيانات التقرير القادم
٢٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.54
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+3.85%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-3.57%
Alto Neuroscience Inc. earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, ANRO reported earnings of -0.52 USD per share (EPS) for Q3 25, beating the estimate of -0.68 USD, resulting in a 23.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of -0.54 USD, with revenue projected to reach -- USD, implying an زيادة of 3.85% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Alto Neuroscience Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Alto Neuroscience Inc. reported EPS of -$0.52, beating estimates by 23.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Alto Neuroscience Inc.'s Q3 2025 earnings?
The stock price moved up 5.97%, changed from $13.40 before the earnings release to $14.20 the day after.
When is Alto Neuroscience Inc. expected to report next?
The next earning report is scheduled for ٢٠ مارس ٢٠٢٦.
What are the forecasts for Alto Neuroscience Inc.'s next earnings report?
Based on 12
المحللين, Alto Neuroscience Inc. is expected to report EPS of -$0.54 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان